Investigating the relationship between rosacea and use of vasodilatory medications in a hospital-wide population - 18/11/21

| Funding sources: Access to resources from the University of Iowa, Institute of Clinical and Translational Science Biomedical Informatics and Biostatistics was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002537. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. |
|
| IRB approval status: Human Subject Research Determination reviewed and approved by HawkIRB; determined not human subject research, approval #201912267. |
|
| This Research Letter was accepted for poster and oral presentation at the 2020 American Academy of Dermatology Annual Meeting in Denver, Colorado (canceled due to COVID-19). |
|
| Reprints not available from the author(s). |
Vol 85 - N° 6
P. 1626-1627 - décembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
